Xavier Chauchet
Light Chain Bioscience
Plan, GR, Switzerland
Plan, GR, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Structural analysis of light chain-driven bispecific antibodies targeting CD47 and PD-L1.
Journal: mAbs
Published: June 08, 2024
CD47xCD19 bispecific antibody triggers recruitment and activation of innate immune effector cells in a B-cell lymphoma xenograft model.
Journal: Experimental hematology & oncology
Published: January 21, 2022
Preclinical Development of a Bispecific Antibody that Safely and Effectively Targets CD19 and CD47 for the Treatment of B-Cell Lymphoma and Leukemia.
Journal: Molecular cancer therapeutics
Published: November 07, 2017
Poly-functional and long-lasting anticancer immune response elicited by a safe attenuated Pseudomonas aeruginosa vector for antigens delivery.
Journal: Molecular therapy oncolytics
Published: August 25, 2016
Triggering the apoptosis of targeted human renal cancer cells by the vibration of anisotropic magnetic particles attached to the cell membrane.
Journal: Nanoscale
Published: September 15, 2015
Live-attenuated bacteria as a cancer vaccine vector.
Journal: Expert review of vaccines
Published: October 16, 2013
Cellular and molecular mechanisms activating the cell death processes by chalcones: Critical structural effects.
Journal: Toxicology in vitro : an international journal published in association with BIBRA
Published: July 03, 2013
A safe bacterial microsyringe for in vivo antigen delivery and immunotherapy.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: March 28, 2013
Bacterial vectors for active immunotherapy reach clinical and industrial stages.
Journal: Human vaccines & immunotherapeutics
Published: August 17, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026